September 28, 2021
Skye Bioscience Announces $7.0 Million Registered Direct Offering
SAN DIEGO, CA, Sept. 27, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, CA, Sept. 27, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical…
OCALA, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of a…
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting…
Proven commercial leader with broad global experience in building and running commercial organizations and successfully launching products for people with…
Announces Results of Annual Meeting of ShareholdersTORONTO and HOUSTON, Sept. 23, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or…
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous…
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing…
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on…
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on…
Key highlights include real-world health outcomes data for pneumonia and skin infections, data on in vitro activity against B. anthracis,…